Agricultural and Veterinary Chemicals Code (Conditions of Approval or Registration) Order 2021

The instrument builds around a small set of tightly defined legal concepts. Those concepts determine when the conditions are triggered and what documentary duties follow.

Manufacturing law (s 4). The operative definition matters. “Manufacturing law, in relation to a country, or part of a country, means a law that provides for the licensing (however described) of the manufacture of agricultural chemical products or active constituents for agricultural chemical products.” The definition is limited: it points to statutory or regulatory regimes that provide for licensing of manufacture. Other regulatory requirements unrelated to a licensing regime (for example, voluntary standards, general environmental laws, or non‑licensing safety rules) are outside the instrument’s compact definition unless they also amount to licensing.

Supply (ss 5(2), 6(2)). The trigger for the prohibition is supply. If manufacture of the active constituent or product contravenes, or fails to comply with, any relevant manufacturing law of the country or part of the country where it is manufactured, the product “must not be supplied.” The instrument does not define “supply”; the term is used in the Code and operative contextually. The prohibition is therefore on supplying approved constituents or registered products that were manufactured in breach of a relevant licensing law.

Documentary evidence on request (ss 5(3), 6(3)). Holders must provide written evidence within 28 days of a written APVMA request that manufacture does not contravene, or fail to comply with, any applicable manufacturing law. The instrument prescribes neither the form nor the substantive content required for the written evidence; it requires only that it be written and provided within 28 days. The APVMA’s broader information powers under the Code are noted in the instrument and can be used in tandem (notes refer to ss 130 and 159 of the Code).

Connection to the Code (ss 5(1), 6(1), notes). The conditions are prescribed “for the purposes of paragraph 23(1)(a) of the Code,” meaning they operate as conditions attached to approvals and registrations under the statutory framework of the Code. The instrument references how contraventions are enforced under the Code: suspension or cancellation under s 36 and potential criminal or civil penalty exposure for supply in contravention (sections 77 for active constituents and 79 for products, by the instrument’s notes).

Temporal application and commencement (s 2, s 7). The instrument expressly applies to supply on or after commencement (s 7). The commencement provision (s 2 and its table) fixes the commencement date as 29 October 2021 for the instrument as originally made. The instrument signals that the commencement table is historical material and not part of the instrument (s 2(2)).

Authority and scope (s 3). The Minister’s power to make the order is drawn from the Agricultural and Veterinary Chemicals Code Act 1994. The instrument notes that s 7 of that Act permits the Minister to make orders with respect to most matters that regulations under s 6 of that Act may deal with.

Interplay with other APVMA powers (notes to ss 5 and 6). The instrument does not stand alone: it adds conditions that sit alongside the APVMA’s existing statutory mechanisms to require information and to take administrative action for contraventions. The notes explicitly identify those related Code provisions as part of the enforcement framework, and they therefore signal how the new conditions will be operationalised within the Code’s existing machinery.

This instrument primarily affects four groups: holders of approvals for active constituents, holders of registrations for agricultural chemical products, manufacturers (including offshore manufacturers), and suppliers or distributors who supply products into Australia on or after the commencement date.

Approval‑ and registration‑holders (ss 5(3), 6(3)). The legal duty to respond to an APVMA written request sits on the holder of the approval or registration. That person must provide written evidence within 28 days that manufacture did not contravene or fail to comply with any applicable manufacturing law. The instrument does not confine the documentary request to only domestic holders; it applies to the holder wherever located because the obligations are attached to approvals and registrations under the Code.

Manufacturers (ss 5(2), 6(2), s 4 definition). The substantive prohibition applies where the manufacturing process contravenes a manufacturing law of the country or part of the country in which manufacture occurs. Manufacturers in jurisdictions that have licensing regimes for manufacture will therefore be indirectly affected because the holder must ensure the manufacture complied with those licensing laws; that will commonly require cooperation from the manufacturer, such as providing certificates, licences, audits, or other evidence. For manufacturers in jurisdictions without licensing laws (as per the statutory definition), the condition references “any manufacturing law,” which is a matter of textual interpretation: if no manufacturing law exists, the condition is not triggered by a licensing requirement in that jurisdiction. The instrument imposes no direct licensing requirement on Australian importers or domestic manufacturers; it imposes a compliance‑and‑proof condition tied to the existence of a foreign or local licensing law.

Suppliers and distributors. The instrument’s operative prohibition is that an approved active constituent or a registered product must not be supplied if its manufacture contravened the relevant manufacturing law (ss 5(2), 6(2)). That makes suppliers and distributors exposed to the risk that a product they supply could be unlawful to supply if it was manufactured in contravention of a licensing law. The instrument’s notes remind that supplying in contravention may attract offences or civil penalties under the Code (notes to ss 5 and 6 referencing ss 77 and 79).

APVMA and Ministerial actors (s 3, notes). The APVMA is the enforcing administrative agency with the power to request information and evidence (referenced in the conditions and notes to ss 5 and 6), and it has existing powers under the Code to suspend or cancel approvals and registrations for contraventions of a condition (note reference to s 36). The Minister is the decision‑maker who made the order under the Act (s 3).

Secondary participants: counsel, auditors and legal advisers. Because the instrument creates an evidentiary duty without specifying formats, holders are likely to procure legal opinions, translated licences, manufacturing licences, certificates of compliance, third‑party audit reports, and contractual representations from manufacturers to meet the 28‑day deadline, implicating external advisers and auditors.

Timing and supply window (s 7). The instrument applies to supply on or after commencement (s 7). Parties that supplied products before the commencement date fall outside its temporal operation. The commencement table records 29 October 2021 as the operative date for the instrument as made.

In aggregate, the instrument puts the legal onus on holders to verify and document manufacturing compliance with any local licensing law of the manufacturing jurisdiction, and it places suppliers and distributors at risk of regulatory action if they supply products manufactured in contravention of those laws.

The instrument creates a narrow set of duties and leaves certain rights implicit through the Code’s existing enforcement powers. Below are the concrete duties, the timeframe attaching to them, and the rights or enforcement tools that the instrument activates indirectly through the Code.

Primary duties on holders of approvals and registrations (ss 5(3), 6(3)). The holder must, on written request by the APVMA, provide written evidence within 28 days after the request is given that the manufacture of the active constituent or the chemical product does not contravene, or fail to comply with, any manufacturing law of the country, or part of the country, in which it is manufactured. The duty is reactive (triggered by a written request), time‑bounded (28 days), and documentary (the evidence must be written).

Prohibition on supply (ss 5(2), 6(2)). The instrument expressly states that the active constituent or the chemical product “must not be supplied” if the manufacture contravenes, or fails to comply with, any applicable manufacturing law. That is a substantive, black‑letter prohibition on supplying products manufactured in breach of a licensing/regulatory obligation in the manufacturing jurisdiction.

Definition duty (s 4). The holder must identify the relevant “manufacturing law” because the operative test is compliance with any manufacturing law of the country or part of the country where manufacture occurs. The instrument’s definition constrains what counts as a manufacturing law , only laws that provide for licensing of manufacture.

Rights of the APVMA (notes to ss 5 and 6). The APVMA can require additional information and documents under the Code (notes refer to ss 130 and 159). The instrument makes those existing powers relevant to enforcement of the new conditions. The APVMA may also suspend or cancel approvals or registrations for contravention of a condition (note referring to s 36). Those notes indicate the administrative remedies available to the APVMA if holders fail to comply with the documentary duty or supply prohibition.

Potential criminal or civil exposure (notes to ss 5 and 6). The instrument’s notes link supply in contravention of the conditions to the Code’s offence and civil penalty provisions: for active constituents, see s 77; for registered products, see s 79. The instrument itself does not create new criminal offences, but it feeds into the Code’s existing penalty structure.

Temporal duty (s 7). The duties apply to products or constituents supplied on or after commencement. Holders must therefore ensure that supplies from the commencement date onwards comply with the manufacture/non‑contravention requirement and be prepared to provide written evidence within 28 days if requested after that date.

Procedural silence. The instrument does not prescribe the form, standard, or content of the written evidence, nor does it state who bears the burden of proof beyond the holder’s obligation to provide the evidence on request. The absence of a prescribed evidentiary standard creates administrative discretion for the APVMA to accept or reject the evidence using its existing powers under the Code to request further information (s 130; s 159 referenced in notes).

Interrelationship with supply contracts. The holder’s duties will generally require contractual mechanisms with manufacturers that secure necessary licences and documentary proof within the 28‑day window. The instrument does not itself create contractual rights between holders and manufacturers, but it makes such contractual protections practically necessary.

Summary: duties are narrow but targeted , a prohibition on supplying items manufactured in breach of a licensing law and a mandatory, short‑deadline documentary obligation on holders when APVMA requests. Rights for enforcement are drawn from the Code rather than the instrument itself, and the instrument intentionally integrates with the Code’s information and enforcement provisions.

The instrument does not impose new statutory penalties within its text, but it expressly connects the new conditions to the Code’s enforcement framework. The instrument therefore operates by making non‑compliance a contravention of an approval or registration condition, which brings the Code’s existing enforcement tools into play.

Administrative enforcement: suspension and cancellation (notes to ss 5 and 6; reference to s 36 of the Code). The instrument’s notes state that the APVMA may suspend or cancel an approval or registration for contravention of a condition of approval or registration, and they cite s 36 of the Code. That means breaching the instrument’s conditions , for example, failing to provide the required written evidence within 28 days after an APVMA request, or supplying a constituent or product manufactured in contravention of a manufacturing law , may expose the holder to administrative action by the APVMA. Suspension or cancellation removes the legal basis to supply the active constituent or the chemical product in Australia while the suspension or cancellation lasts.

Criminal and civil penalty exposure (notes to ss 5 and 6; references to ss 77 and 79 of the Code). The instrument’s notes identify that a person may commit an offence or contravene a civil penalty provision if they supply an approved active constituent or a registered chemical product in contravention of the conditions. The specific offence and civil penalty provisions are in ss 77 (referenced for active constituents) and 79 (referenced for registered products) of the Code. The instrument itself does not restate those penalty provisions, but by embedding the conditions into approvals and registrations, it makes those provisions applicable to the contravention.

Information and document powers (notes to ss 5 and 6; references to ss 130 and 159 of the Code). The instrument reminds holders that the APVMA may also require persons to provide information and documents under the Code. Those powers operate in parallel to the 28‑day evidentiary duty in the instrument and permit the APVMA to go beyond the written evidence the instrument expressly requires, subject to the Code’s own procedural and legal limits.

Operational discretion for APVMA. Because the instrument sets no evidentiary standard for the “written evidence” and attaches the enforcement options to contraventions of conditions under the Code, the APVMA retains administrative discretion to assess the sufficiency of the evidence, to seek further information under s 130 or s 159, and to exercise administrative remedies (suspension, cancellation) where the conditions are breached.

Time sensitivity and enforcement risk. The 28‑day deadline is a short statutory timeframe. Failure to meet the deadline exposes the holder to immediate enforcement risk through the Code’s mechanisms. The instrument does not provide for extensions or specify circumstances in which late provision of evidence will be excused; those procedural matters would therefore fall to the APVMA’s administrative practice or potential judicial review if contested.

Enforcement against third parties. The instrument places the duty on holders of approvals and registrations. Suppliers and distributors that supply products manufactured in contravention of a manufacturing law may be liable under the Code’s supply provisions (notes reference ss 77 and 79). The instrument does not spell out enforcement priorities among parties, but the Code’s existing enforcement architecture will determine whether APVMA action targets holders, manufacturers, importers or suppliers.

No new direct criminal offences in the instrument. The instrument itself creates conditions and documentary duties; it links to existing criminal and civil penalty provisions in the Code but does not create new standalone offences or fine scales in its own text.

In practical terms, enforcement will proceed under the Code using the APVMA’s document‑production powers, administrative remedies for contraventions of conditions, and the Code’s offence and civil penalty provisions when supply occurs despite non‑compliance.

The instrument is explicitly designed to operate within, and to trigger consequences under, the Agricultural and Veterinary Chemicals Code Act 1994 and the regulatory powers of the APVMA. It also engages foreign regulatory regimes by reference to manufacturing laws in the country or part of the country in which manufacture occurs.

Integration with the Code (ss 5(1), 6(1) and notes). The conditions are prescribed “for the purposes of paragraph 23(1)(a) of the Code,” thereby attaching to approvals and registrations created and administered under the Code. The instrument makes APVMA information powers (ss 130 and 159 of the Code) and remedies for contravention of a condition (s 36) directly relevant. The instrument’s notes also point to ss 77 and 79 of the Code for offence and civil penalty consequences. In short, the instrument does not stand alone; it imports the Code’s investigative, administrative and enforcement apparatus.

Interaction with foreign regulatory regimes (s 4 definition; ss 5(2), 6(2)). The instrument expressly requires compliance with any “manufacturing law of the country, or part of the country, in which it is manufactured.” That brings foreign domestic licensing regimes into the Australian regulatory decision chain. The instrument’s definition of “manufacturing law” restricts the foreign laws that matter to those that provide for licensing of manufacture. Other foreign regulatory obligations that do not take the form of a licensing law fall outside the instrument’s formal scope.

Potential interplay with import, customs and trade laws. The instrument addresses supply post‑manufacture; it does not directly alter customs or import tariff regimes. However, because the instrument conditions supply on compliance with foreign licensing laws, importers and customs brokers will need to align import practices and declarations with proof that manufacture complied with any applicable foreign licensing law if requested by APVMA. The instrument does not amend import disclosure obligations in customs law, but it creates a regulatory compliance overlay that could interact operationally with import documentation and supply chain declarations.

Contract and commercial law consequences. The new documentary and compliance obligations will interact with commercial contracts between holders and manufacturers or suppliers. To meet the instrument’s documentary duty and to ensure supply lawfulness, approval‑ and registration‑holders will need contractual representations, warranties and indemnities from manufacturers and suppliers, and practical clauses obliging manufacturers to produce licences or certification on request. The instrument does not itself create contractual rights, but it alters the factual environment in which parties negotiate manufacturing and supply agreements.

Administrative law and judicial review. The APVMA’s exercise of discretion in accepting or rejecting “written evidence” and in deciding whether to suspend or cancel approvals and registrations remains subject to administrative law standards. The instrument does not alter judicial review availability, but disputes about the adequacy of documentary proof or the APVMA’s exercise of enforcement powers could give rise to judicial review under existing administrative law remedies.

Overlap with domestic occupational health, environmental and general licensing laws. The instrument’s definition limits its domestic reach to licensing laws that provide for licensing of manufacture. Other Australian laws (for example, environmental approvals, occupational health and safety regulations, chemical control laws outside the Code) may also apply to manufacture; those laws remain applicable but are not directly referenced unless they constitute a licensing manufacturing law as defined in the instrument.

No cross‑reference to labelling or marketing laws. The instrument does not create new labelling or marketing obligations (for example, to identify country of manufacture). It focuses on manufacture and documentary proof; any interaction with labelling law would be indirect and arise from other statutory regimes or voluntary quality standards.

Overall, the instrument functions as a regulatory bridge between the APVMA’s approval/registration framework and manufacturing licensing regimes in manufacturing jurisdictions, while relying on the Code’s existing investigatory and enforcement provisions. Parties must navigate a web of domestic administrative law, foreign licensing regimes, commercial contracts, and supply chain documentation to comply.

The instrument’s text records its original making and commencement but contains no amendments in the version provided. The recorded making details and commencement table show the instrument as originally made and provide the commencement date.

Original making and maker. The instrument is the Agricultural and Veterinary Chemicals Code (Conditions of Approval or Registration) Order 2021. It is signed by David Littleproud, Minister for Agriculture and Northern Australia, dated 13 July 2021 (front matter). Section 3 records the statutory authority under the Agricultural and Veterinary Chemicals Code Act 1994.

Commencement. Section 2 contains a commencement table. In column 2 the instrument states that “The whole of this instrument” commences “The day after the end of the period of 3 months beginning on the day this instrument is registered.” The table records that as 29 October 2021. Section 2(2) clarifies that the information in column 3 of the table is not part of the instrument and that the table relates only to the provisions as originally made.

No subsequent amendments recorded in the instrument. The instrument includes the standard note that the commencement table relates only to the provisions as originally made and will not be amended to deal with later amendments. The text provided contains no later amendment provisions, no repeal language and no transitional modifications beyond what is set out in Part 3. Part 3 contains the single provision that the instrument applies to supply on or after the commencement of the instrument (s 7). There are no savings clauses, grandfathering provisions, or staged compliance measures recorded in the text supplied.

Implication for users: the instrument is presented as a concise, self‑contained order made once under the Code Act. Any later amendments would need to be made by subsequent instrument and would not be reflected in the table in the text as provided. Where a user needs to know whether later amendments exist, that must be checked in the consolidated instrument register or the Federal Register of Legislation, because the instrument itself notes the table is not amended to reflect later changes.

No amendment history entries, explanatory amendments, or transitional fine‑grained phased commencement steps appear in the provided text beyond the single commencement date and the simple application provision for supply on or after commencement.

The instrument as supplied contains no litigation history. It does not record any judicial proceedings, decisions, or appeals concerning its validity, interpretation or enforcement. The instrument’s notes point users to relevant Code provisions that carry enforcement consequences (ss 36, 77, 79, 130, 159), but it supplies no case law or administrative decisions applying the instrument.

What the instrument records and what that implies:

• No recorded cases in the text. There are no cases named in the instrument and no references to judicial interpretation of the conditions it prescribes.
• Enforcement would rely on the Code’s existing machinery. Because the instrument links contravention of the conditions to the Code’s suspension, cancellation and offence/civil penalty provisions, any litigation that arises would be under or related to the Code’s provisions rather than under the instrument itself. Therefore litigation, if any, will primarily concern administrative law challenges to APVMA actions, interpretation of the manufacturing law definition, or supply‑related offence proceedings under the Code.
• Potential judicial issues (not recorded as having occurred). The instrument raises a number of discrete legal questions that could be litigated, for example: the legal standard or sufficiency of the “written evidence” the APVMA may require; the interpretation of “manufacturing law” in complex federal systems or where regulatory competence is shared within parts of a country; whether manufacture “contravenes, or fails to comply with” a foreign licensing law when the licensing law is ambiguous or differently framed; and procedural fairness issues related to suspension or cancellation actions taken for contravention of the new conditions. None of these hypothetical issues are reflected in the instrument as it stands.

If parties face enforcement action or refuse to supply, litigation would likely be recorded against the APVMA decisions under the Administrative Decisions (Judicial Review) Act or in judicial review proceedings challenging the APVMA’s exercise of powers under the Code. Because the provided text contains no litigation history, practitioners should search the Federal Court and administrative law databases, and APVMA decision registers, to identify any reported litigation or tribunal decisions that post‑date the instrument’s commencement.

The instrument is short, but it contains multiple practical traps and ambiguities that create compliance and operational risk if not addressed. The following points are specific, grounded in the text, and will matter in practice.

1. “Manufacturing law” is narrowly defined (s 4) and therefore not all foreign regulatory requirements matter. The instrument makes the condition depend on a law that “provides for the licensing (however described) of the manufacture.” Regulatory obligations that take the form of standards, certifications, product registrations, export permits, or general environmental or safety obligations that do not function as licensing schemes fall outside the literal definition. Practically, a holder must identify whether the foreign regime is a licensing law as defined; users should not assume any foreign regulatory requirement will trigger the instrument.

2. The condition applies to the manufacturing jurisdiction or part thereof (ss 5(2), 6(2)). That means a single multinational manufacturer operating in multiple sites may be subject to different manufacturing laws across different sites. Holders must map manufacturing locations precisely: the condition attaches to the law of the country or part of the country “in which it is manufactured.” A manufacturer operating in a country where some subnational jurisdictions license manufacture and others do not may create asymmetric obligations.

3. “Must not be supplied” is absolute (ss 5(2), 6(2)). If manufacture contravenes the relevant manufacturing law, supply is prohibited. The instrument does not create a remedial timeframe or cure period to fix manufacturing compliance once a contravention is identified. The absence of a cure mechanism means any identified contravention could immediately render supply unlawful under the approval/registration condition, triggering enforcement consequences under the Code.

4. Documentary proof requirement is short and unspecified (ss 5(3), 6(3)). The holder must provide “written evidence” within 28 days of an APVMA written request. The instrument does not define acceptable forms of written evidence (licence copies, third‑party audits, certificates, sworn statements, translations, legal opinions, etc.). This leaves room for dispute about sufficiency, and it places a premium on pre‑planning to hold responsive documentation. There is also no provision for reasonable extensions if evidence is held abroad or needs translation.

5. The instrument relies on the APVMA’s general information powers. The notes to ss 5 and 6 point to ss 130 and 159 of the Code. If the APVMA considers the written evidence insufficient, it can exercise its Code powers to require further documents. Holders should treat the instrument’s 28‑day response as a first step, not the final step in regulatory engagement.

6. No standard for “contravene or fail to comply” (ss 5(2), 6(2)). The instrument does not specify whether minor administrative non‑compliance in a foreign licensing regime that does not relate to product safety (for example, an expired procedural licence) would render supply unlawful. That grey area can be an enforcement friction point and a litigation vector.

7. Application limited to supply on or after commencement (s 7). Supplies made before the commencement date are out of scope. Practically, that creates a date‑line issue: stock manufactured before commencement but supplied after may be in scope if its manufacture contravened a manufacturing law. The instrument applies in relation to goods “that is supplied on or after the commencement” (s 7), so the date of supply is the operative trigger, not the date of manufacture alone.

8. Who must hold the evidence? The statutory duty to provide evidence on APVMA request is placed on the holder of the approval or registration (ss 5(3), 6(3)). If that holder is not the manufacturer (for example, the holder is an Australian registrant or importer), they need contractual access to the manufacturer’s licences and records. Failure to secure contractual evidence routes is a commercial risk.

9. Jurisdictional complexity for multi‑part manufacturing chains. Active constituents may be manufactured, blended, packed and labelled in multiple jurisdictions. The instrument focuses on the jurisdiction “in which it is manufactured.” Where manufacture is split across jurisdictions, the holder should document compliance at each relevant stage and location to meet an APVMA request.

10. No requirement to change labelling or declare country of manufacture. The instrument does not change labelling law and does not require declarations on labelling of country of manufacture. That means the documentary obligation is internal and administrative unless the APVMA exercises its powers publicly by suspension or cancellation.

11. Absence of an amendment or transitional regime in the instrument as provided. The instrument contains no transitional relief or phased compliance. This could be a practical problem for registrants with long supply chains who need to gather evidence from overseas manufacturers that may not be set up to provide prompt documentary proof.

12. Potential mismatch between local administrative calendars and the 28‑day deadline. Holidays, regional administrative delays, or licensing renewal cycles in manufacturing jurisdictions might impede the fast 28‑day turnaround. The instrument does not provide for leniency, so operational planning is necessary.

13. Evidence in a foreign language. The instrument requires written evidence but says nothing about language, translation standards, or authentication. Holders should be ready to provide certified translations, apostilles or legalised documents to avoid disputes about authenticity.

14. The instrument does not contest the foreign law’s content or adequacy. It requires compliance with the foreign licensing law, not assessment of whether that law meets Australian safety standards. This creates a compliance test focused on legal form (licensing) rather than regulatory equivalence or outcomes.

These are the principal risks and traps that flow from the instrument’s text. They point to practical measures holders should adopt pre‑emptively to prevent enforcement risk and to respond to APVMA requests efficiently.

Compliance with this instrument requires a small number of concrete, documentable steps because the duties it imposes are targeted: ensure manufacture does not contravene any applicable licensing law of the manufacturing jurisdiction and be able to produce written evidence within 28 days of an APVMA request.

1. Map manufacturing footprint and applicable laws. For every approved active constituent and every registered product you hold, create and maintain a register that identifies:
   • precise manufacturing sites (address, legal entity, site managers);
   • the country and, where relevant, the part of the country (state/province) where manufacture occurs;
   • the applicable “manufacturing law” in that jurisdiction (i.e. the licensing law that provides for licensing of manufacture);
   • the licence type or regulatory instrument that is the licensing law (statute, regulation, permit, licence number and issuing authority);
   • licence issue and expiry dates and any conditions attached to the licence.

This mapping responds directly to the instrument’s requirement to ensure manufacture does not contravene any manufacturing law (ss 5(2), 6(2)) and to the instrument’s definition of “manufacturing law” (s 4).

2. Secure documentary proof and an evidence repository. For each manufacturing site, obtain and keep up‑to‑date copies (and where relevant, certified copies and translations) of:
   • the manufacturing licence or permit itself, including any sub‑licenses, renewals, or endorsements;
   • third‑party audit reports, compliance certificates, or inspection reports demonstrating ongoing compliance with the licensing conditions;
   • written declarations or warranties from the manufacturer confirming compliance with applicable licensing laws;
   • supporting documents such as registration certificates, environmental approvals where they form part of licensing conditions, or proof of fee payments where relevant.

Store these in a secure, searchable, time‑stamped repository that can produce the required “written evidence” within 28 days of an APVMA request (ss 5(3), 6(3)). Ensure authorised staff know the repository location and retrieval procedures.

3. Contractual protections with manufacturers and suppliers. Amend or include the following clauses in manufacturing and supply contracts:
   • representations and warranties that the manufacturer holds all required manufacturing licences and is in compliance with them;
   • an obligation on the manufacturer to deliver copies of licences and other required documents on request within a timeframe that allows the holder to meet the 28‑day requirement;
   • cooperation clauses obliging the manufacturer to provide further information and to permit audits if needed for APVMA compliance;
   • indemnities against losses, fines, or enforcement action resulting from manufacturer non‑compliance with licensing laws;
   • notification clauses requiring advance notice of any regulatory enforcement, licence suspension, expiry, or change in legal status.

These contractual steps ensure the holder can meet the documentary duty and mitigate commercial risk.

4. Operational readiness for APVMA requests. Designate a compliance officer or team responsible for APVMA communications. Ensure that:
   • the APVMA receives a prompt written response within the 28‑day statutory deadline;
   • evidence is compiled in the requested written form and, where necessary, certified or translated;
   • there is a pre‑agreed chain of escalation if documents are not available within the 28‑day window (for example, immediate notification to management, engagement of external counsel or auditors to secure rapid certification or attestation).

Treat the 28‑day window as firm: the instrument imposes a hard 28‑day deadline and does not provide for extensions in its text (ss 5(3), 6(3)).

5. Prepare for multi‑jurisdictional manufacture. If different stages of manufacture occur across jurisdictions, obtain evidence for each relevant site. Clarify whether the APVMA request relates to the active constituent’s manufacture, the product’s formulation, filling/packing, or raw material manufacture, and be ready to produce site‑specific compliance documents.

6. Anticipate translation and authentication needs. Documents from overseas manufacturers are likely to be in a foreign language and may require certified translation, notarisation, apostilles or legalisation depending on the document type. Build lead time for authentication and translation, and store both original language documents and certified translations in your repository.

7. Maintain records of supply timelines. Because the instrument applies to supply on or after commencement (s 7), maintain clear records of manufacture dates, shipment dates, and supply dates to demonstrate whether a particular batch falls within the instrument’s operation. If a batch was manufactured before commencement, but supplied after, document that chain.

8. Audit and internal compliance checks. Undertake periodic audits of manufacturing sites and supply chains, focusing on licence validity, compliance with the licensing conditions, and the integrity of documentary evidence. Use internal or third‑party auditors to create additional records that can be produced to APVMA as written evidence where appropriate.

9. Liaise with APVMA where uncertainties arise. If it is unclear whether a foreign requirement qualifies as a “manufacturing law” as defined in s 4, or if evidence is ambiguous, proactively consult the APVMA before supplying goods. Early engagement may reduce enforcement risk and clarify acceptable forms of evidence.

10. Insure and manage commercial risk. Consider insurance, contractual indemnities and contingent supply options for scenarios in which a manufacturer’s licence is revoked or otherwise becomes non‑compliant and supply must be halted. Diversify supply sources where feasible to reduce single‑source dependency.

11. Document compliance policies and staff training. Prepare internal policies that set out how to respond to APVMA requests, the responsibilities of procurement, quality, regulatory and legal teams, and the steps to obtain and verify the required evidence. Provide training to procurement and quality staff who interact with overseas manufacturers.

12. Keep contemporaneous communication records. Save copies of all APVMA correspondence, evidence submitted, and any acknowledgements received from APVMA. Those records will be vital if enforcement action or administrative review follows.

By implementing these steps, a holder positions itself to meet the instrument’s documentary duty promptly and to reduce the risk of supplying products manufactured in breach of applicable licensing laws. The compliance programme should be proportionate to the scale and complexity of the holder’s supply chains and periodically reviewed to capture regulatory or operational changes.